Dissolving Microneedles Loading TPGS Biphasic Functionalized PLGA Nanoparticles for Efficient Chemo‐Photothermal Combined Therapy of Melanoma

Tingting Peng,Yao Huang,Xiaoqian Feng,Chune Zhu,Xiangyu Ma,Xinyi Wang,Xuequn Bai,Xin Pan,Chuanbin Wu

DOI: https://doi.org/10.1002/adtp.201900190

IF: 5.003

2020-02-24

Advanced Therapeutics

Abstract:The poly (lactic‐co‐glycolic acid) nanoparticle (PLGA NP) has been widely used in the biomedical field. However, it is insensitive to degradation upon laser irradiation, resulting in a limited increase in drug release, which compromises the therapeutic efficacy. To actively promote drug release, the biphasic α‐tocopheryl succinate (TPGS) functionalized PLGA NPs (PTNPs) are developed by introducing TPGS into the aqueous and organic phase to generate pores in the PLGA core during preparation. Paclitaxel and indocyanine green are encapsulated in the PTNPs to realize chemo‐photothermal combined therapy, and PTNPs are delivered through dissolving microneedles (DMNs) for local treatment in melanoma. PTNPs show enhanced drug release and improved cytotoxicity due to their greater ability in inhibiting cell microtubule depolymerization. In vivo tumor suppression investigation and ki‐67 immunohistochemical staining of tumor tissue further show the superiority of PTNPs loaded DMNs against tumor growth, and photothermal therapy synergistically enhances the chemotherapeutic effect of PTNPs. Moreover, the living imaging of mice demonstrates that the drug is successfully retained in the tumor tissue to avoid it entering into the circulation and producing adverse effects. Therefore, the PTNPs loaded DMNs show a favorable prospect in the treatment of superficial tumor. α‐Tocopheryl succinate (TPGS) biphasic functionalized poly (lactic‐co‐glycolic acid) nanoparticles (PTNPs) are developed to actively facilitate drug release by using TPGS as a pore‐forming agent. In addition, the integration of PTNPs and dissolving microneedles (DMNs) technique avoids frequent administration and off‐target side effects. Effective treatment in melanoma is achieved through a single local administration of PTNPs loaded DMNs with chemo‐photothermal combined therapy.